More recently, fasting regimens, such as caloric restriction and intermittent fasting (IF), have been shown to reduce body mass, serum insulin concentration, blood pressure (BP), and inflammation, and to improve insulin sensitivity and the lipid profile, thereby reducing the risk for metabolic disease [2–5]. Here, INS is linked to metabolic disease.